MedPath
FDA Approval

Escitalopram Oral Solution

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chartwell RX, LLC
DUNS: 079394054
Effective Date
September 1, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Escitalopram(5 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Chartwell Pharmaceuticals Carmel, LLC

Chartwell RX, LLC

118673485

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Escitalopram Oral Solution

Product Details

NDC Product Code
62135-729
Application Number
ANDA090477
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 1, 2023
SORBITOL SOLUTIONInactive
Code: 8KW3E207O2Class: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
Code: 5U85DBW7LOClass: ACTIMQuantity: 5 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath